Barrow, Hanley, Mewhinney & Strauss
QDEL icon

Barrow, Hanley, Mewhinney & Strauss’s QuidelOrtho QDEL Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-78
Closed -$1.28K – 420
2026
Q1 		$1.28K Hold
78
– – ﹤0.01% 351
2025
Q4 		$2.23K Hold
78
– – ﹤0.01% 311
2025
Q3 		$2.3K Buy
+78
New +$2.13K ﹤0.01% 311
2022
Q1 		– Sell
-493,958
Closed -$66.7M – 335
2021
Q4 		$66.7M Buy
493,958
+13,427
+3% +$1.87M 0.21% 97
2021
Q3 		$67.8M Buy
+480,531
New +$64.6M 0.22% 89

Other funds holding QDEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's QDEL Position: Q2 2026 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of QuidelOrtho (QDEL) in Q2 2026, closing a stake of 78 shares — an estimated $1.28K sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in QDEL in Q3 2021 and held it in 5 quarters. The position peaked at $67.8M in Q3 2021. 245 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining QuidelOrtho position as of Q2 2026 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 78 QuidelOrtho shares in Q2 2026, an estimated $1.28K.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in QuidelOrtho in Q3 2021 and held it in 5 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's QuidelOrtho position peaked at $67.8M in Q3 2021.
  • 245 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.